CEO
RxE2 Inc.
Fargo, North Dakota
Gerald E. Finken, R.Ph., M.S., is a licensed pharmacist and has over 41 years of experience in the biotechnology and pharmaceutical industries. In 1997, he founded CSM, a clinical supplies packaging and labeling company, where he invented On-Demand packaging and labeling, Clinical Trial Research Pharmacist (CTRP®) services, and pioneered Direct-to-Patient services. In 2013, he founded Center Point Clinical Services and subsequently created the innovative Siteless CRO model. In 2020 he launched RxE2 to incorporate the practice of pharmacy into clinical trials. He currently serves as CEO of RxE2.
Mr. Finken focuses on innovation, disruptive business strategies, and growth opportunities.
Monday, October 23, 2023
7:00 AM – 9:00 AM ET